[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
August 11, 2015

Incorrect Trial Description, Reference Numbering, and Case Description

JAMA. 2015;314(6):628. doi:10.1001/jama.2015.8794

In the Care of the Aging Patient article entitled “Polypharmacy in the Aging Patient: Management of Hypertension in Octogenarians” published in the July 14, 2015, issue of JAMA,1 an item in the Results section was reworded to provide clarity. The description of a recent trial should have read: “A recent trial showed that the association between blood pressure and mortality was related to the frailty marker walking speed: in faster walkers, SBP was positively correlated with mortality. Among slower walkers, blood pressure was not associated with mortality. In those unable to complete the walk test, blood pressure was negatively associated with risk of death.” In the Discussion section, reference citation numberings from 54 onward were corrected. In the Clinical Cases: Managing Polypharmacy in Older Patients section, the description of case 2 should have reported the dosage for atorvastatin as “40 mg, once daily.” This article was corrected online.

Benetos  A, Rossignol  P, Cherubini  A,  et al.  Polypharmacy in the aging patient: management of hypertension in octogenarians. JAMA. 2015;314(2):170-180.PubMedArticle